Home

overview

This program aims to improve the recognition, diagnosis, and management of indolent systemic mastocytosis (ISM) by addressing unmet needs in diagnostic and treatment pathways. Participants will gain knowledge of ISM disease mechanisms, risk factors, and clinical clues, including red flags and mimics, while exploring case-based challenges and common presentations in allergy settings. The importance of multidisciplinary care teams in expediting diagnosis and ensuring comprehensive care will be emphasized.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

SPEAKER

Mariana Castells, MD, PhD

Editor in Chief Current Allergy and Asthma Reports, Director Drug Hypersensitivity and Desensitization Center

Director Mastocytosis Center

Brigham and Women's Hospital

Professor of Medicine, Harvard Medical School

Boston, Massachusetts

SPEAKER

Matthew Giannetti, MD

Assistant Professor of Medicine

Harvard Medical School

Associate Director Mastocytosis Center

Brigham and Women's Hospital

Boston, Massachusetts

TARGET AUDIENCE

This educational activity is intended for an audience of allergists/clinical immunologists, hematologists/oncologists, dermatologists, gastroenterologists, nurse practitioners, physician assistants, and nurses in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to recognize ISM, improve use of appropriate diagnostic tools, and improve collaboration within multidisciplinary teams to ensure optimal patient outcomes.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: [break][break] Have increased knowledge regarding [LIST] [ITEM]Treatment advances in ISM[/LIST][break]Have greater competence related to [LIST] [ITEM]Early recognition and diagnosis of ISM[/LIST][break]Demonstrate greater confidence in their ability to [LIST] [ITEM]Collaborate within a multidisciplinary team, ensuring comprehensive care for ISM patients[/LIST]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold][break] Medscape, LLC designates this live activity for a maximum of 0.50 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [break] [break] [bold]For Nurses[/bold] [break] Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs. [break] [break] [bold]For Pharmacists[/bold] [break] Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-25-100-L01-P).

New Frontiers in Managing Indolent Systemic Mastocytosis CME/CNE/CPE